Identification of Thr283 as a key determinant of P2X7 receptor function

被引:41
作者
Young, M. T. [1 ]
Pelegrin, P. [1 ]
Surprenant, A. [1 ]
机构
[1] Univ Sheffield, Western Bank, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
基金
英国惠康基金;
关键词
purine receptor; ion channel; biotinylation; patch clamp; dye uptake; mutagenesis;
D O I
10.1038/sj.bjp.0706880
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: The ATP-gated P2X(7) receptor is an unusual ion channel that couples to multiple downstream signalling cascades. We noted differences in mouse cDNA sequences that may indicate polymorphisms; the aim of this study was to compare function and expression of these mouse P2X(7) receptor mutations. Experimental approach: There are three differences in the sequences of P2X(7) cDNA cloned from mouse NTW8 microglial cells or C57 BL/6 mice: [Phe(11), Ala(221), Met(283)]P2X(7) in the former and [Leu(11), Thr(221), Thr(283)]P2X(7) in the latter. We expressed these receptors and measured membrane currents, ethidium uptake, calcium influx and surface membrane expression. We also carried out these assays on the previously described polymorphism observed between C57 BL/6 and Balb/c mice ([Leu(451)]P2X(7) vs [Pro(451)]P2X(7)). Key results: Maximum current densities at [Phe(11), Ala(221), Met(283)]P2X(7) were < 12% of those at [Leu(11), Thr(221), Thr(283)]P2X(7) without change in the agonist concentration-response. Replacing methionine with threonine at residue 283 yielded a receptor whose properties were the same as [Leu(11), Thr(221), Thr(283)]P2X(7). Replacing T283 in the rat P2X(7) receptor with methionine yielded currents that were < 10% of wildtype and no ethidium uptake was associated with its activation. Maximum current densities and agonist EC50 values were the same at mouse [Thr(283), Leu(451)]P2X(7) and [Thr(283), Pro(451)]P2X(7) but ethidium uptake and Fluo4 fluorescence were significantly reduced at the [Thr(283), Leu(451)]P2X(7) receptor. There was equivalent surface membrane expression of all P2X7 receptors. Conclusions: This study has revealed a residue (Thr(283)) in the ectodomain that is critical for P2X(7) receptor function and suggests that the intracellular residue 451 alters downstream signalling independently of ion channel activity.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 42 条
  • [1] Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors
    Adinolfi, E
    Kim, M
    Young, MT
    Di Virgilio, F
    Surprenant, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 37344 - 37351
  • [2] Cutting edge: A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor
    Adriouch, S
    Dox, C
    Welge, V
    Seman, M
    Koch-Nolte, F
    Haag, F
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (08) : 4108 - 4112
  • [3] Novel P2X7 receptor antagonists
    Alcaraz, L
    Baxter, A
    Bent, J
    Bowers, K
    Braddock, M
    Cladingboel, D
    Donald, D
    Fagura, M
    Furber, M
    Laurent, C
    Lawson, M
    Mortimore, M
    McCormick, M
    Roberts, N
    Robertson, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 4043 - 4046
  • [4] Hit-to-lead studies:: The discovery of potent adamantane amide P2X7 receptor antagonists
    Baxter, A
    Bent, J
    Bowers, K
    Braddock, M
    Brough, S
    Fagura, M
    Lawson, M
    McInally, T
    Mortimore, M
    Robertson, M
    Weaver, R
    Webborn, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 4047 - 4050
  • [5] Pharmacological characterization of recombinant human and rat P2X receptor subtypes
    Bianchi, BR
    Lynch, KJ
    Touma, E
    Niforatos, W
    Burgard, EC
    Alexander, KM
    Park, HS
    Yu, HX
    Metzger, R
    Kowaluk, E
    Jarvis, MF
    van Biesen, T
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 376 (1-2) : 127 - 138
  • [6] Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
    Chessell, IP
    Hatcher, JP
    Bountra, C
    Michel, AD
    Hughes, JP
    Green, P
    Egerton, J
    Murfin, M
    Richardson, J
    Peck, WL
    Grahames, CBA
    Casula, MA
    Yiangou, Y
    Birch, R
    Anand, P
    Buell, GN
    [J]. PAIN, 2005, 114 (03) : 386 - 396
  • [7] Effects of antagonists at the human recombinant P2X7 receptor
    Chessell, IP
    Michel, AD
    Humphrey, PPA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) : 1314 - 1320
  • [8] Cloning and functional characterisation of the mouse P2X7 receptor
    Chessell, IP
    Simon, J
    Hibell, AD
    Michel, AD
    Barnard, EA
    Humphrey, PPA
    [J]. FEBS LETTERS, 1998, 439 (1-2) : 26 - 30
  • [9] Properties of the pore-forming P2X(7) purinoceptor in mouse NTW8 microglial cells
    Chessell, IP
    Michel, AD
    Humphrey, PPA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (07) : 1429 - 1437
  • [10] Di Virgilio Francesco, 2001, Trends in Pharmacological Sciences, V22, P5